Bringing the fundamentals into focus…
Back to LB Pharmaceuticals Inc
How LB Pharmaceuticals Inc stacks up
LBRX · against 440 other Healthcare companies of similar size
Profitability
11/ 100
Near the bottom of its peers.
Ranked #402 of 441 · scores higher than 8% of peers
Bars: peers in each 10-point band of the profitability score42 peers with a profitability score of 10–19, including LBRX · Click a bar to see the companies
Why profitability scores 11?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 95% of peers. Return on invested capital: -152.6% vs peer median 4.7%
- a lower return on assets: weaker than 83% of peers. Return on assets: -23.7% vs peer median 1.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = LBRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LBRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 417 reported | -152.6% | 5.3% | 5% | 33% | |
| Operating marginHigher is better · 416 reported | Not reported | 7.0% | — | — | 33% |
| Return on assetsHigher is better · 428 reported | -23.7% | 1.8% | 15% | 33% | |
| Return on equityHigher is better · 412 reported | -50.0% | 3.2% | 13% | Context only | |
| Gross marginHigher is better · 460 reported | 0.0% | 47.3% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around LBRX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 914M USD | 99 | 81 | |
| 399 | 1.3B USD | 12 | 27 | |
| 399 | 1.3B USD | 12 | 33 | |
| 399 | 2.2B USD | 12 | 35 | |
| 402 | 660M USD | 11 | 43 | |
| 402 | 1.3B USD | 11 | 39 | |
| 402 | 2.2B USD | 11 | 48 | |
| 402 | 1.2B USD | 11 | 40 | |
| 402 | 976M USD | 11 | 36 | |
| 407 | 9.9B HKD (≈$1.3B) | 9 | 17 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score